Evidence map›Paper›PMID 31097791›Full record

ReviewNature reviews. Cardiology2019

Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes.

Jason H Y Wu, Renata Micha, Dariush Mozaffarian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 4 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 4 syntheses or guidelines pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Postprandial inflammation across the aging spectrum.The journal of nutrition, health & aging · 2025
    Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jason H Y WuThe George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia. jwu1@georgeinstitute.org.au.ORCID http://orcid.org/0000-0003-2073-3562
Renata MichaFriedman School of Nutrition Science & Policy, Tufts University, Boston, MA, USA.
Dariush MozaffarianFriedman School of Nutrition Science & Policy, Tufts University, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7958-9492
Tufts University · USUNSW Sydney · AU

Funding

Cost-Effectiveness of Health System and State-Level Strategies to Improve Diet and Reduce Cardiometabolic DiseasesR01HL115189 · NHLBI · TUFTS UNIVERSITY BOSTON · PI DARIUSH MOZAFFARIAN · 2013 to 2026
$8.2M
Economic Analyses of Policy Strategies to Improve Diet and Reduce CVDR01HL130735 · NHLBI · TUFTS UNIVERSITY BOSTON · PI MICHA, EIRINI (RENATA) · 2016 to 2019
$3.1M
NHLBI NIH HHS R01 HL115189NHLBI NIH HHS R01 HL130735
6 · The paper itself

Abstract

The effect of dietary fats on cardiometabolic diseases, including cardiovascular diseases and type 2 diabetes mellitus, has generated tremendous interest. Many earlier investigations focused on total fat and conventional fat classes (such as saturated and unsaturated fats) and their influence on a limited number of risk factors. However, dietary fats comprise heterogeneous molecules with diverse structures, and growing research in the past two decades supports correspondingly complex health effects of individual dietary fats. Moreover, health effects of dietary fats might be modified by additional factors, such as accompanying nutrients and food-processing methods, emphasizing the importance of the food sources. Accordingly, the rapidly increasing scientific findings on dietary fats and cardiometabolic diseases have generated debate among scientists, caused confusion for the general public and present challenges for translation into dietary advice and policies. This Review summarizes the evidence on the effects of different dietary fats and their food sources on cell function and on risk factors and clinical events of cardiometabolic diseases. The aim is not to provide an exhaustive review but rather to focus on the most important evidence from randomized controlled trials and prospective cohort studies and to highlight current areas of controversy and the most relevant future research directions for understanding how to improve the prevention and management of cardiometabolic diseases through optimization of dietary fat intake.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2AnimalsCell MembraneDietary FatsDiet, Carbohydrate-RestrictedDiet, Fat-RestrictedFatty AcidsFoodGene Expression RegulationGlycated HemoglobinHumansLipidsMeta-Analysis as TopicObservational Studies as TopicRandomized Controlled Trials as TopicDietary FatsFatty AcidsGlycated Hemoglobinhemoglobin A1c protein, humanLipids

Identifiers

PMID31097791
OpenAlexW2946513226

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.